202 related articles for article (PubMed ID: 18095030)
1. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors.
Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
Ann Surg Oncol; 2008 Mar; 15(3):782-90. PubMed ID: 18095030
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
5. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Gao HJ; Liang HH; Chen MS; Peng ZW; Zhang YJ; Li P; Pang XH; Zhang YQ; Li JQ
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2529-32. PubMed ID: 19080642
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation.
Izumi N; Asahina Y; Noguchi O; Uchihara M; Kanazawa N; Itakura J; Himeno Y; Miyake S; Sakai T; Enomoto N
Cancer; 2001 Mar; 91(5):949-56. PubMed ID: 11251946
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
Tateishi R; Shiina S; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Yoshida H; Kawabe T; Omata M
Cancer; 2005 Mar; 103(6):1201-9. PubMed ID: 15690326
[TBL] [Abstract][Full Text] [Related]
12. Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
Tsai MC; Wang JH; Hung CH; Kee KM; Yen YH; Lee CM; Hu TH; Chen CH; Lu SN
J Gastroenterol Hepatol; 2010 Mar; 25(3):605-12. PubMed ID: 20074164
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
14. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
[TBL] [Abstract][Full Text] [Related]
15. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
16. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
[TBL] [Abstract][Full Text] [Related]
18. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
[TBL] [Abstract][Full Text] [Related]
19. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
Yang W; Chen MH; Gao W; Wu W; Huo L; Dai WD; Liu WY; Yan K
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):169-73. PubMed ID: 16635345
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
